Join
Live feed
·
INSIDERFilingvia Quantisnow
Vincerx Pharma Inc. logo

SEC Form 4: Thomas Tom C bought $4,750 worth of shares (5,000 units at $0.95), increasing direct ownership by 2% to 219,935 units

ByQuantisnow·Wall Street's wire, on your screen.
VINC· Vincerx Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VINC (Vincerx Pharma Inc.) and more on Quantisnow.